Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CareDx, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CDNA
Nasdaq
2836
caredx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CareDx, Inc.
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting
- Apr 21st, 2026 2:01 pm
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
- Apr 20th, 2026 5:05 am
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns
- Apr 19th, 2026 8:07 pm
All You Need to Know About CareDx (CDNA) Rating Upgrade to Buy
- Apr 17th, 2026 10:00 am
Are Medical Stocks Lagging CareCloud (CCLD) This Year?
- Apr 17th, 2026 7:40 am
Why Diagnostics Names CareDx And QuidelOrtho Just Diverged
- Apr 16th, 2026 2:28 pm
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
- Apr 15th, 2026 2:30 pm
How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy Risks
- Apr 15th, 2026 1:04 am
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
- Apr 14th, 2026 2:01 pm
Exploring 3 High Growth Tech Stocks in the US Market
- Mar 26th, 2026 11:38 am
CareDx (CDNA) Launches AI-based Platform VANTx
- Mar 24th, 2026 8:43 am
How The CareDx (CDNA) Story Is Shifting With CMS LCD Uncertainty And New Guidance
- Mar 16th, 2026 9:19 am
CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference
- Mar 7th, 2026 3:02 pm
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
- Mar 5th, 2026 2:01 pm
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Feb 27th, 2026 2:01 pm
CareDx, Inc Q4 2025 Earnings Call Summary
- Feb 25th, 2026 6:02 pm
CareDx Inc (CDNA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...
- Feb 24th, 2026 10:04 pm
CareDx Q4 Earnings Call Highlights
- Feb 24th, 2026 9:11 pm
CareDx (CDNA) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 24th, 2026 6:00 pm
CareDx (CDNA) Q4 Earnings Miss Estimates
- Feb 24th, 2026 5:30 pm
Scroll